De-risk market acess.
Accellerate portfolio revenue
You back the innovation. We build the scalable business.
Buoyancy Health Strategy bridges the gap between technical excellence and healthcare adoption. We partner with HealthTech and MedTech investors to accelerate market entry, optimize business models, and provide fractional C-suite commercial leadership that turns portfolio companies into scalable, fundable market leaders.
How we create value for your portfolio
Entering complex healthcare systems is notorious for slow adoption, institutional friction, and wasted capital.
We transform reactive go-to-market efforts into focused, system-aligned execution:
Accelerated market access
We break through healthcare system friction by aligning portfolio products directly with health system priorities and defining clear adoption pathways.
Capital-efficient commercialisation
We turn innovations into fundable businesses by designing health-specific business models and go-to-market plans and scaling revenue without the immediate overhead of full-time senior hires.
We identify and activate new revenue streams, assess international markets for strategic fit, and align product portfolios to real-world clinical demand.
Targeted revenue expansion
Precision support across the investment journey
Early-stage / Post-seed
Go-to-Market & traction
How we move the needle:
Designing scalable health-specific business models and crafting value propositions that land with clinical decision-makers and economic buyers.
Pre-deal / seed
Valuation & diligence
How we move the needle:
Building fundable, investor-ready business cases and assessing product-market fit within complex healthcare systems.
Exits & restructuring
Commercial optimisation
How we move the needle:
Supporting post-merger integration (PMI) for commercial directorates, optimising capabilities, and aligning organisational structures for scale.
Growth / Series A+
Expansion & scaling
How we move the needle:
Prioritising international market entry, identifying new B2B/B2G revenue streams, and aligning product portfolios to sustained market demand.
Our track record of scalable growth
2x revenue growth and NHS adoption
We assisted a medical device start-up in re-engineering their go-to-market strategy, directly securing NHS adoption, scaling operations, and doubling revenue.
5-year global capital allocation strategy
We conducted a global market analysis for a leading diagnostics company to identify high-margin expansion opportunities and focus investment priorities for a 5-year growth horizon.
Commercial post-merger integration
Led post-merger integration for the commercial directorate of a national healthcare organization, aligning roles, structural shape, and commercial capabilities.
Why investors partner with us
What sets Buoyancy Health Strategy apart is our ability to combine commercial strategy with deep health system insider knowledge:
Over 15 years of sector expertise
Proven track record as a business strategist and consulting professional across MedTech, HealthTech, and pharma.
Buyer-side leadership experience
Direct executive leadership positions within acute hospital provider organisations and payer/commissioning. We know how healthcare buyers evaluate risk, allocate budget, and adopt innovation.
Delivered projects across twelve countries in Europe, the Middle East, and Southeast Asia, bringing an international perspective to market expansion.
Global execution
Let's explore what this could look like for your portfolio
Share with visitors how they can contact you and encourage them to ask any questions they may have.
Buoyancy Health Strategy
Steady. Strategic. Scalable Healthcare Growth
© 2025 Buoyancy Health Strategy Ltd. All rights reserved.